Vascular changes in eyes treated with dexamethasone intravitreal implant for macular edema after retinal vein occlusion

Ophthalmology

Volumn 120, Issue 7, 2013, Pages 1423-1431

  Sadda, Srinivas ^a   Danis, Ronald P ^b   Pappuru, Rajeev R ^c   Keane, Pearse A ^d   Jiao, Jenny ^e   Li, Xiao Yan ^e   Whitcup, Scott M ^e  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c L V PRASAD EYE INSTITUTE   (India)

^d MOORFIELDS EYE HOSPITAL   (United Kingdom)

^e ALLERGAN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE;

ARTICLE; BRANCH RETINAL VEIN OCCLUSION; CAPILLARY LEAK SYNDROME; CENTRAL RETINA VEIN OCCLUSION; CENTRAL RETINAL THICKNESS; CLINICAL EVALUATION; CORRELATION ANALYSIS; FLUORESCENCE ANGIOGRAPHY; HUMAN; INCIDENCE; INTRAVITREAL IMPLANT; MAJOR CLINICAL STUDY; MULTICENTER STUDY (TOPIC); NEOVASCULARIZATION (PATHOLOGY); OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PHASE 3 CLINICAL TRIAL (TOPIC); POST HOC ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETINA ANGIOGRAPHY; RETINA HEMORRHAGE; RETINA MACULA EDEMA; STATISTICAL SIGNIFICANCE; VISUAL ACUITY; VISUAL IMPAIRMENT;

ADULT; AGED; AGED, 80 AND OVER; BLOOD-RETINAL BARRIER; CAPILLARY PERMEABILITY; DEXAMETHASONE; DOUBLE-BLIND METHOD; DRUG IMPLANTS; FEMALE; FLUORESCEIN ANGIOGRAPHY; GLUCOCORTICOIDS; HUMANS; MACULAR EDEMA; MALE; MIDDLE AGED; RETINAL HEMORRHAGE; RETINAL NEOVASCULARIZATION; RETINAL VEIN OCCLUSION; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; VITREOUS BODY;

EID: 84879797619     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2012.12.021     Document Type: Article

References (17)

1. F.L. Ferris III, A. Patz Macular edema A complication of diabetic retinopathy Surv Ophthalmol 28 suppl 1984 452 461
2. R.L. McIntosh, S.L. Rogers, L. Lim Natural history of central retinal vein occlusion: an evidence-based systematic review Ophthalmology 117 2010 1113 1123
3. S.L. Rogers, R.L. McIntosh, L. Lim Natural history of branch retinal vein occlusion: an evidence-based systematic review Ophthalmology 117 2010 1094 1101
4. D.A. Antonetti, A.J. Barber, S. Khin Penn State Retina Research Group Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells Diabetes 47 1998 1953 1959
5. P.A. Campochiaro, G. Hafiz, S.M. Shah Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator Mol Ther 16 2008 791 799
6. S. Scholl, J. Kirchhof, A.J. Augustin Pathophysiology of macular edema Ophthalmologica 224 suppl 2010 8 15
7. J.A. Haller, F. Bandello, R. Belfort Jr OZURDEX GENEVA Study Group Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion Ophthalmology 117 2010 1134 1146
8. J.A. Haller, F. Bandello, R. Belfort Jr Ozurdex GENEVA Study Group Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion: twelve-month study results Ophthalmology 118 2011 2453 2460
9. Central Vein Occlusion Study Group Natural history and clinical management of central retinal vein occlusion Arch Ophthalmol 115 1997 486 491
10. D.M. Brown, P.A. Campochiaro, R.B. Bhisitkul Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study Ophthalmology 118 2011 1594 1602
11. P.A. Campochiaro, D.M. Brown, C.C. Awh Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study Ophthalmology 118 2011 2041 2049
12. SCORE Study Research Group A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5 Arch Ophthalmol 127 2009 1101 1114
13. SCORE Study Research Group A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6 Arch Ophthalmol 127 2009 1115 1128
14. C.K. Chan, M.S. Ip, P.C. VanVeldhuisen SCORE Study Investigator Group SCORE Study report #11: incidences of neovascular events in eyes with retinal vein occlusion Ophthalmology 118 2011 1364 1372
15. W. Buehl, S. Sacu, U. Schmidt-Erfurth Retinal vein occlusions Dev Ophthalmol 46 2010 54 72
16. M. Al-Latayfeh, P.S. Silva, J.K. Sun, L.P. Aiello Antiangiogenic therapy for ischemic retinopathies Cold Spring Harb Perspect Med [serial online] 2 2012 a006411 http://perspectivesinmedicine.cshlp.org/content/2/6/a006411.long Accessed November 13, 2012
17. I.U. Scott, P.C. VanVeldhuisen, N.L. Oden Standard Care versus COrticosteroid for REtinal Vein Occlusion Study Investigator Group Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10 Ophthalmology 118 2011 345 352